When evaluating a patient with angioedema, two of the most important criteria to consider are (1) whether the mechanism of swelling is from mast cell activation or another cause (especially bradykinin but potentially including other mast cell–independent mediators or mechanisms affecting vascular permeability) and (2) whether it is hereditary or acquired. The gene discussed is KNG1; the disease is angioedema.